Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2021-12, Vol.35 (12), p.3573-3577
Hauptverfasser:	Harrington, Patrick, de Lavallade, Hugues, Doores, Katie J., O’Reilly, Amy, Seow, Jeffrey, Graham, Carl, Lechmere, Thomas, Radia, Deepti, Dillon, Richard, Shanmugharaj, Yogita, Espehana, Andreas, Woodley, Claire, Saunders, Jamie, Curto-Garcia, Natalia, O’Sullivan, Jennifer, Raj, Kavita, Kordasti, Shahram, Malim, Michael H., Harrison, Claire N., McLornan, Donal P.
Format:	Artikel
Sprache:	eng
Schlagworte:	13/21 13/31 631/250/255 692/308/575 692/699/1541/1990/2331 82/1 Antibodies Antibodies, Neutralizing - immunology Antibodies, Viral - immunology Cancer Research Care and treatment Coronaviruses COVID-19 - complications COVID-19 - prevention & control COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - immunology Critical Care Medicine Drug dosages Health aspects Hematology Humans Immunization Infections Intensive Internal Medicine Letter Lymphocytes T Medicine Medicine & Public Health Messenger RNA mRNA mRNA Vaccines Myeloproliferative disorders Myeloproliferative Disorders - immunology Neoplasms Oncology Patients SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 T cells T-Lymphocytes - immunology Tumors Vaccines Vaccines, Synthetic - administration & dosage Vaccines, Synthetic - immunology Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!